108 related articles for article (PubMed ID: 17475453)
1. Biological conversion of a water-soluble prodrug of cyclosporine A.
Lallemand F; Varesio E; Felt-Baeyens O; Bossy L; Hopfgartner G; Gurny R
Eur J Pharm Biopharm; 2007 Sep; 67(2):555-61. PubMed ID: 17475453
[TBL] [Abstract][Full Text] [Related]
2. Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.
Lallemand F; Felt-Baeyens O; Rudaz S; Hamel AR; Hubler F; Wenger R; Mutter M; Besseghir K; Gurny R
Eur J Pharm Biopharm; 2005 Jan; 59(1):51-6. PubMed ID: 15567301
[TBL] [Abstract][Full Text] [Related]
3. A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
Lallemand F; Perottet P; Felt-Baeyens O; Kloeti W; Philippoz F; Marfurt J; Besseghir K; Gurny R
Eur J Pharm Sci; 2005 Sep; 26(1):124-9. PubMed ID: 15978789
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble prodrugs of cyclosporine A with tailored conversion rates.
Hamel AR; Hubler F; Mutter M
J Pept Res; 2005 Mar; 65(3):364-74. PubMed ID: 15787967
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
Rodriguez-Aller M; Kaufmann B; Guillarme D; Stella C; Furrer P; Rudaz S; El Zaoui I; Valamanesh F; Di Tommaso C; Behar-Cohen F; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
[TBL] [Abstract][Full Text] [Related]
6. A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.
Lallemand F; Furrer P; Felt-Baeyens O; Gex-Fabry M; Dumont JM; Besseghir K; Gurny R
Int J Pharm; 2005 May; 295(1-2):7-14. PubMed ID: 15847987
[TBL] [Abstract][Full Text] [Related]
7. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
8. Water soluble cyclosporine monomethoxy poly(ethyleneglycol) conjugates as potential prodrugs.
Cho H; Chung Y
Arch Pharm Res; 2004 Jun; 27(6):662-9. PubMed ID: 15283470
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol.
Kumpulainen H; Järvinen T; Mannila A; Leppänen J; Nevalainen T; Mäntylä A; Vepsäläinen J; Rautio J
Eur J Pharm Sci; 2008 Jul; 34(2-3):110-7. PubMed ID: 18403185
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing a phosphate ester prodrug from its isobaric sulfate metabolite by mass spectrometry without the metabolite standard.
Wu ST; Cao K; Bonacorsi SJ; Zhang H; Jemal M
Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3107-13. PubMed ID: 19714709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs.
Niemi R; Huuskonen J; Laine K; Järvinen T
Int J Pharm; 2005 May; 295(1-2):121-7. PubMed ID: 15847997
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vivo conversion of new water-soluble sulfenamide prodrugs of carbamazepine.
Hemenway JN; Nti-Addae K; Guarino VR; Stella VJ
Bioorg Med Chem Lett; 2007 Dec; 17(23):6629-32. PubMed ID: 17928225
[TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
16. The use of quadrupole-time-of-flight mass spectrometer for the elucidation of diclofenac biotransformation products in wastewater.
Kosjek T; Zigon D; Kralj B; Heath E
J Chromatogr A; 2008 Dec; 1215(1-2):57-63. PubMed ID: 19036379
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A prodrugs: design, synthesis and biophysical properties.
Hamel AR; Hubler F; Carrupt A; Wenger RM; Mutter M
J Pept Res; 2004 Feb; 63(2):147-54. PubMed ID: 15009536
[TBL] [Abstract][Full Text] [Related]
18. First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS.
Pérez S; Barceló D
Anal Chem; 2008 Nov; 80(21):8135-45. PubMed ID: 18821734
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic stability of 2'-ethylcarbonate-linked paclitaxel in serum and conversion to paclitaxel by rabbit liver carboxylesterase for use in prodrug/enzyme therapy.
Tanino T; Nawa A; Miki Y; Iwaki M
Biopharm Drug Dispos; 2008 Jul; 29(5):259-69. PubMed ID: 18496885
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of cyclosporin A: identification of 1,11 seco-cyclosporin A and 4,5 seco-isocyclosporin A by FAB-MS/MS.
Magni F; Arnoldi L; Del Puppo M; Galli Kienle M
Peptides; 1995; 16(8):1335-41. PubMed ID: 8745041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
